DHG Pharmaceutical JSC (HOSE:DHG)

Market Cap	13.55T +2.1%
Revenue (ttm)	4.98T +0.4%
Net Income	891.34B +10.8%
EPS	6,816.87 +10.8%
Shares Out	130.75M
PE Ratio	15.20
Forward PE	13.38
Dividend	10,000.00 (9.71%)
Ex-Dividend Date	n/a

Volume	26,814
Average Volume	20,659
Open	103,000
Previous Close	103,000
Day's Range	102,600 - 103,600
52-Week Range	87,000 - 110,700
Beta	0.41
RSI	50.05
Earnings Date	Jan 21, 2026

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in health food, dietary and consumer health supplements, and pharmaceuticals cosmetic products. It also exports its products. DHG Pharmaceuti...

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 2,819
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DHG

Financial Performance

In 2024, DHG Pharmaceutical JSC's revenue was 4.88 trillion, a decrease of -2.60% compared to the previous year's 5.02 trillion. Earnings were 753.55 billion, a decrease of -25.91%.